Fund Holdings — Blue Owl Capital Holdings LP

Total Portfolio Value:
$359.56M
Total Bought:
$53.71M
Total Sold:
$132.79M
Net Transaction:
-$79.08M
Securities
▲▼
SharesValue
Q1 2024
▲▼
Q2 2024
▲▼
Change
▲▼
Q1 2024
▲▼
Q2 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Cullinan Therapeutics, Inc.(CGEM)2,924,8422,049,172-875,670$49.84M$35.74M9.94%-$14.10M
Pliant Therapeutics, Inc.(PLRX)3,004,1993,004,1990$44.76M$32.30M8.98%-$12.47M
Blue Owl Capital Corporation(OBDC)2,045,0702,045,0700$31.45M$31.41M8.74%-$40.9K
Klaviyo, Inc.COM SER A(KVYO)1,198,2701,198,2700$30.53M$29.82M8.29%-$707.0K
Larimar Therapeutics, Inc.(LRMR)3,994,4683,859,468-135,000$30.32M$27.98M7.78%-$2.34M
Engene Holdings Inc
COM
2,461,3502,449,827-11,523$41.72M$23.10M6.43%-$18.62M
Tourmaline Bio Inc1,447,4011,715,401+268,000$31.99M$22.06M6.14%-$9.93M
EverCommerce Inc.(EVCM)1,641,9291,641,9290$15.47M$18.03M5.01%+$2.56M
Acelyrin Inc2,826,0282,926,028+100,000$19.08M$12.90M3.59%-$6.17M
Repare Therapeutics Inc3,122,4993,372,499+250,000$14.71M$11.13M3.10%-$3.58M
Ultragenyx Pharmaceutical Inc.(RARE)268,238268,2380$12.52M$11.02M3.07%-$1.50M
Context Therapeutics Inc.(CNTX)05,161,290+5,161,290$0$10.35M2.88%+$10.35M
Disc Medicine, Inc.(IRON)155,260215,260+60,000$9.67M$9.70M2.70%+$35.3K
Toast, Inc.CL A(TOST)322,578322,5780$8.04M$8.31M2.31%+$274.2K
E2open Parent Holdings IncCL A1,650,9431,650,9430$7.33M$7.41M2.06%+$82.5K
Keros Therapeutics, Inc.(KROS)172,633157,633-15,000$11.43M$7.20M2.00%-$4.22M
Ikena Oncology Inc3,891,1184,091,118+200,000$5.53M$6.75M1.88%+$1.22M
Sagimet Biosciences Inc.COM SER A(SGMT)1,673,8771,673,8770$9.07M$5.72M1.59%-$3.35M
Mineralys Therapeutics, Inc.(MLYS)541,080450,339-90,741$6.99M$5.27M1.47%-$1.72M
Viking Therapeutics, Inc.(VKTX)095,000+95,000$0$5.04M1.40%+$5.04M
Inozyme Pharma Inc1,270,0271,120,027-150,000$9.73M$5.00M1.39%-$4.73M
Starwood Property Trust, Inc.SHS(STWD)0226,456+226,456$0$4.29M1.19%+$4.29M
Pyxis Oncology, Inc.(PYXS)01,046,025+1,046,025$0$3.46M0.96%+$3.46M
Mereo BioPharma Group plcADS(MREO)0897,809+897,809$0$3.23M0.90%+$3.23M
Aquestive Therapeutics Inc875,0001,140,000+265,000$3.73M$2.96M0.82%-$763.5K
Compass Therapeutics, Inc.(CMPX)2,829,7122,829,7120$5.60M$2.83M0.79%-$2.77M
ADC Therapeutics SASHS(ADCT)733,568733,5680$3.29M$2.32M0.64%-$975.6K
Omega Therapeutics Inc1,055,8821,055,8820$3.85M$2.19M0.61%-$1.67M
Structure Therapeutics IncADS055,000+55,000$0$2.16M0.60%+$2.16M
Immunovant, Inc.(IMVT)100,00080,000-20,000$3.23M$2.11M0.59%-$1.12M
Syros Pharmaceuticals Inc340,855340,8550$1.82M$1.76M0.49%-$64.8K
Janux Therapeutics, Inc.(JANX)040,000+40,000$0$1.68M0.47%+$1.68M
Celcuity Inc.(CELC)065,000+65,000$0$1.06M0.30%+$1.06M
Blend Labs, Inc.CL A(BLND)361,587361,5870$1.18M$853.4K0.24%-$321.8K
Gohealth IncCL A83,26483,2640$875.1K$814.6K0.23%-$60.5K
Engene Holdings IncW EXP 10 31 202
*W EXP 10/31/202
511,17751,177-460,000$2.66M$608.3K0.17%-$2.05M
Plum Acquisition Corp IiiUNIT 03 31 2028070,000+70,000$0$324.0K0.09%+$324.0K
Desktop Metal IncCL A0750,000+750,000$0$309.8K0.09%+$309.8K
Precision BioSciences, Inc.(DTIL)20,22020,2200$274.2K$196.7K0.05%-$77.4K
Geron Corporation(GERN)023,918+23,918$0$101.4K0.03%+$101.4K
Plum Acquisition Corp IiiW EXP 03 31 202666,666666,6660$0$46.7K0.01%+$46.7K
Fathom Digital Mfg CorpCL A50,0000-50,000$230.5K$0—-$230.5K
Desktop Metal IncCL A750,0000-750,000$660.0K$0—-$660.0K
GitLab Inc.(GTLB)20,7060-20,706$1.21M$0—-$1.21M
Uber Technologies, Inc.(UBER)23,9180-23,918$78.9K$0—-$78.9K
Braze, Inc.SHS(BRZE)116,1530-116,153$2.36M$0—-$2.36M
Dell Technologies Inc.SHS(DELL)41,2450-41,245$4.71M$0—-$4.71M
Snowflake Inc.SHS(SNOW)7,8190-7,819$1.26M$0—-$1.26M
Robinhood Markets, Inc.CL A(HOOD)4,237,4090-4,237,409$53.98M$0—-$53.98M
Black Diamond Therapeutics I695,0000-695,000$3.52M$0—-$3.52M
Direxion Shs Etf TrDAILY S P BIOTEC490,0000-490,000$3.57M$0—-$3.57M
Enliven Therapeutics Inc25,0000-25,000$439.8K$0—-$439.8K
Madrigal Pharmaceuticals, Inc.(MDGL)13,3190-13,319$3.56M$0—-$3.56M
MoonLake ImmunotherapeuticsCL A(MLTX)100,0000-100,000$5.02M$0—-$5.02M
Ovid Therapeutics Inc.(OVID)864,8220-864,822$2.64M$0—-$2.64M
Rallybio Corporation(RLYB)350,2400-350,240$647.9K$0—-$647.9K
Page 1 of 1
Blue Owl Capital Holdings LP — 13F Holdings — Q2 2024 | TickerTrail